Discovering therapeutic antibodies designed by nature

Partnering opportunities with AIMM Therapeutics

AIMM has a long history of partnering with the research community and commercial partners. These partnerships range from antibody specific deals for advancing candidates through clinical trials (i.e., Crucell/J&J and Medimmune/AZ), to academic research programs. AIMM intends to continue pursuing the broad utilization of its technology platforms and welcomes proposals from third parties that target diseases of high unmet medical need.

Commercial partners have multiple opportunities to work with AIMM including

Academic collaborators are invited to submit proposals for working with AIMM.